Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Am J Respir Cell Mol Biol ; 67(1): 76-88, 2022 07.
Article in English | MEDLINE | ID: mdl-35507773

ABSTRACT

Alpha-1 antitrypsin deficiency (AATD) is characterized by neutrophil-dominated inflammation resulting in emphysema. The cholesterol-rich neutrophil outer plasma membrane plays a central role in adhesion and subsequent transmigration to underlying tissues. This study aimed to investigate mechanisms of increased neutrophil adhesion in AATD and whether alpha-1 antitrypsin (AAT) augmentation therapy abrogates this effect. Plasma and blood neutrophils were donated by healthy controls (n = 20), AATD (n = 30), and AATD patients after AAT augmentation therapy (n = 6). Neutrophil membrane protein expression was investigated using liquid chromatography-tandem mass spectrometry. The effect of once-weekly intravenous AAT augmentation therapy was assessed by calcium fluorometric, µ-calpain, and cell adhesion assays. Decreased neutrophil plasma membrane cholesterol content (P = 0.03), yet increased abundance of integrin α-M (fold change 1.91), integrin α-L (fold change 3.76), and cytoskeletal adaptor proteins including talin-1 (fold change 4.04) were detected on AATD neutrophil plasma membrane fractions. The described inflammatory induced structural changes were a result of a more than twofold increased cytosolic calcium concentration (P = 0.02), leading to significant calcium-dependent µ-calpain activity (3.5-fold change; P = 0.005), resulting in proteolysis of the membrane cholesterol trafficking protein caveolin-1. Treatment of AAT-deficient individuals with AAT augmentation therapy resulted in increased caveolin-1 and membrane cholesterol content (111.8 ± 15.5 vs. 64.18 ± 7.8 µg/2 × 107 cells before and after treatment, respectively; P = 0.02), with concurrent decreased neutrophil integrin expression and adhesion. Results demonstrate an auxiliary benefit of AAT augmentation therapy, evident by a decrease in circulating inflammation and controlled neutrophil adhesion.


Subject(s)
Pulmonary Emphysema , alpha 1-Antitrypsin Deficiency , Calcium/metabolism , Caveolin 1/metabolism , Cholesterol/metabolism , Humans , Inflammation/metabolism , Integrins/metabolism , Neutrophils/metabolism , Pulmonary Emphysema/metabolism , alpha 1-Antitrypsin/metabolism
3.
Respir Med ; 185: 106481, 2021.
Article in English | MEDLINE | ID: mdl-34077874

ABSTRACT

Non-invasive respiratory support (NRS) outside of the ICU has played an important role in the management of COVID-19 pneumonia. There is little data to guide selection of NRS modality. We present outcomes of NRS outside the ICU and discuss the effects of NRS on gas exchange with implications for management.


Subject(s)
COVID-19/therapy , Intensive Care Units , Noninvasive Ventilation/methods , Pulmonary Gas Exchange/physiology , SARS-CoV-2 , Aged , Aged, 80 and over , COVID-19/epidemiology , COVID-19/physiopathology , Female , Humans , Male , Middle Aged , Treatment Outcome
4.
Ann Transl Med ; 8(11): 670, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32617290
6.
Lung ; 195(2): 173-177, 2017 04.
Article in English | MEDLINE | ID: mdl-28138789

ABSTRACT

Neuralgic Amyotrophy (NA) or Parsonage-Turner syndrome is an idiopathic neuropathy commonly affecting the brachial plexus. Associated phrenic nerve involvement, though recognised, is thought to be very rare. We present a case series of four patients (all male, mean age 53) presenting with dyspnoea preceded by severe self-limiting upper limb and shoulder pain, with an elevated hemi-diaphragm on clinical examination and chest X-ray. Neurological examination of the upper limb at the time of presentation was normal. Diaphragmatic fluoroscopy confirmed unilateral diaphragmatic paralysis. Pulmonary function testing demonstrated characteristic reduction in forced vital capacity between supine and sitting position (mean 50%, range 42-65% predicted, mean change 23%, range 22-46%), reduced maximal inspiratory pressures (mean 61%, range 43-86% predicted), reduced sniff nasal inspiratory pressure (mean 88.25, range 66-109 cm H2O) and preserved maximal expiratory pressure (mean 107%, range 83-130% predicted). Phrenic nerve conduction studies confirmed phrenic nerve palsy. All patients were managed conservatively. Follow-up ranged from 6 months to 3 years. Symptoms and lung function variables normalised in three patients and improved significantly in the fourth. The classic history of severe ipsilateral shoulder and upper limb neuromuscular pain should be elicited and thus NA considered in the differential for a unilateral diaphragmatic paralysis, even in the absence of neurological signs. Parsonage-Turner syndrome is likely to represent a significantly under-diagnosed aetiology of phrenic nerve palsy. Conservative management as opposed to surgical intervention is advocated as most patients demonstrate gradual resolution over time in this case series.


Subject(s)
Brachial Plexus Neuritis/complications , Brachial Plexus Neuritis/diagnosis , Peripheral Nervous System Diseases/etiology , Phrenic Nerve , Respiratory Paralysis/etiology , Brachial Plexus Neuritis/therapy , Dyspnea/etiology , Humans , Male , Middle Aged , Musculoskeletal Pain/etiology , Neural Conduction , Respiratory Paralysis/therapy , Shoulder Pain/etiology , Upper Extremity
SELECTION OF CITATIONS
SEARCH DETAIL
...